Brandon Barney, MD
Radiation Oncology · American Fork, UTNPI 1194961789
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,755 of the $15,999 with a category attached, or 73.5%. Myovant Sciences Inc. accounts for 80.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $13,847 and has fallen 93.8% since, to $860 in 2025. Among radiation oncology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $399.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$13K
- Reflexion Medical, Inc.$1K
- IBA Proton Therapy, Inc.$645
- Siemens Medical Solutions USA, Inc.$372
- Novocure Inc.$240
- Boston Scientific$122
- plus $312 from 9 others
Across 19 payments — averaging $3202.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sumitomo Pharma America, Inc.$61K
What the payments were for
- Speaking & faculty fees$11,75573%
- Travel & lodging$1,99512%
- Food & beverage$2,24914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 4 | $12,877 |
| Reflexion Medical, Inc. | 9 | $1,430 |
| IBA Proton Therapy, Inc. | 2 | $645 |
| Siemens Medical Solutions USA, Inc. | 2 | $372 |
| Novocure Inc. | 7 | $240 |
| Boston Scientific | 6 | $122 |
| Varian Medical Systems, Inc. | 1 | $94 |
| Palette Life Sciences, Inc. | 2 | $52 |
| Telix Pharmaceuticals | 1 | $41 |
| Bioprotect Medical, Inc. | 1 | $29 |
| AbbVie | 1 | $28 |
| Pfizer | 1 | $23 |
| Teleflex LLC | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORGOVYX$12,877
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM$1,239
- TrueBeam$199
- Varian Ethos Treatment Planning$173
- Varian IDENTIFY$173
- Optune$125
How this compares
$15,999 in reported general payments places this provider in the 95th percentile of 49 radiation oncology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $5,809 |
| Tamsulosin Hcl | 98 | $1,528 |
| Bicalutamide | 17 | $227 |
| Ciprofloxacin Hcl | 35 | $112 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in American Fork
- Jay ClarkAmerican Fork$419
- Jonathan TwardSalt Lake City$114K
- David GaffneySalt Lake City$22K
- Douglas HoltSalt Lake City$3K
- Kristine KokenySalt Lake City$3K
- Matthew PoppeSalt Lake City$2K
- Robert HarrisLayton$2K
- John HayesSalt Lake City$1K
- David PrattProvo$1K
- Stephen GrantSt George$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.